A new link between steroid resistance, glucocorticoid receptor and nuclear factor kappa B p65 in idiopathic nephrotic syndrome

Neuroendocrinology Letters

Volumn 30, Issue 5, 2009, Pages 629-636

  Szilagyi, Katarina ^a   Podracka, Ludmila ^a   Franke, Niels E ^b   Mojzis, Jan ^a   Mirossay, Ladislav ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glucocorticoids; Idiopathic nephrotic syndrome; Peripheral blood cells; Relapse; Sensitivity

Indexed keywords

GLUCOCORTICOID RECEPTOR ALPHA; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PREDNISONE; TRANSCRIPTION FACTOR RELA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG RESPONSE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; IDIOPATHIC NEPHROTIC SYNDROME; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN EXPRESSION; RELAPSE; SCHOOL CHILD;

EID: 77649242814     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aviles DH, Matti W, Manning J, Ochoa AC, Zea AH (2004). Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome. Kidney Int. 66: 60-67.
2. Baeuerle PA, Baltimore D (1996). NF-kappa B: ten years after. Cell. 87: 13-20.
3. Bantel H, Schmitz ML, Raible A, Gregor M, Schulze-Osthoff K (2002). Critical role of NF-kappaB and stress-activated protein kinases in steroid unresponsiveness. FASEB J. 16: 1832-1834.
4. Bloomfield CD, Smith KA, Peterson BA, Munck A (1981). Glucocorticoid receptors in adult acute lymphoblastic leukemia. Cancer Res. 41: 4857-4860.
5. Davies TH, Ning YM., Sanchez ER (2002). A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem. 277: 4597-4600.
6. De Bosscher K., Van den Berghe W., Haegeman G (2003). The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev. 24: 488-522.
7. Ehrich JH, Pape L, Schiffer M (2008). Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis: an update of treatment options for children. Paediatr Drugs. 10: 9-22.
8. Eisen LP, Elsasser MS, Harmon JM (1988). Positive regulation of the glucocorticoid receptor in human T-cells sensitive to the cytolytic effects of glucocorticoids. J Biol Chem. 263: 12044-12048.
9. Gbadegesin R, Smoyer W (2008). Nephrotic syndrome. In: Geary DF, Shaefer F, editors. Comprehensive Pediatric Nephrology, 1st edition. London: Mosby. p. 205-228.
10. Gross KL, Lu NZ, Cidlowski JA (2009). Molecular mechanisms regulating glucocorticoid sensitivity and resistance. Mol Cell Endocrinol. 300: 7-16.
11. Gruber G, Carlet M, Turtscher E, Meister B, Irving JA, Ploner C, et al., (2009). Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis. Leukemia. 23: 820-823.
12. Haack D, Scharer K, Asam-Tauscher A, Vecsei P (1999). Glucocorticoid receptors in idiopathic nephrotic syndrome. Pediatr Nephrol. 13: 653-656.
13. Haarman EG, Kaspers GJ, Pieters R, Rottier MM, Veerman AJ (2004). Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia. Leukemia. 18: 530-537.
14. Han SH, Park SY, Li JJ, Kwak SJ, Jung DS, Choi HY, et al., (2008). Glomerular glucocorticoid receptor expression is reduced in late responders to steroids in adult-onset minimal change disease. Nephrol Dial Transplant. 23: 169-175.
15. Herr I, Gassler N, Friess H, Buchler MW (2007). Regulation of differential pro- and antiapoptotic signaling by glucocorticoids. Apoptosis. 12: 271-291.
16. Honda M, Orii F, Ayabe T, Imai S, Ashida T, Obara T, et al., (2000). Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology. 118: 859-866.
17. Kang BN, Tirumurugaan KG, Deshpande DA, Amrani Y, Panettieri RA, Walseth TF, et al., (2006). Transcriptional regulation of CD38 expression by tumor necrosis factor-alpha in human airway smooth muscle cells: role of NF-kappaB and sensitivity to glucocorticoids. FASEB J. 20: 1000-1002.
18. Kofler R, Schmidt S, Kofler A, Ausserlechner MJ (2003). Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia. J Endocrinol. 178: 19-27.
19. Lane SJ, Atkinson BA, Swaminathan R, Lee TH (1996). Hypothalamic- pituitary-adrenal axis in corticosteroid-resistant bronchial asthma. Am J Respir Crit Care Med. 153: 557-560.
20. McKay LI, Cidlowski JA (1998). Cross-talk between nuclear factorkappa B and the steroid hormone receptors: mechanisms of mutual antagonism. Mol Endocrinol. 12: 45-56.
21. Oerlemans R, Vink J, Dijkmans BA, Assaraf YG, van Miltenburg M, van der Heijden J, et al., (2007). Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor alpha and glucocorticoid induced apoptosis. Ann Rheum Dis. 66: 1289-1295.
22. Onda K, Rimbara E, Hirano T, Oka K, Abe H, Jahara K, et al., (2004). Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis. J Rheumatol. 31: 464-469.
23. Perkins ND (2000). The Rel/NF-kappa B family: friend and foe. Trends Biochem Sci. 25: 434-440.
24. Pui CH, Dahl GV, Rivera G, Murphy SB, Costlow ME (1984). The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk Res. 8: 579-585.
25. Pui CH, Costlow ME (1986). Sequential studies of lymphoblast glucocorticoid receptor levels at diagnosis and relapse in childhood leukemia: an update. Leuk Res. 10: 227-229.
26. Ray A, Prefontaine KE (1994). Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA. 91: 752-756.
27. Sahali D, Pawlak A, Ie Gouvello S, Lang P, Valanciute A, Remy P, et al., (2001). Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol. 12: 1648-1658.
28. Sanchez-Vega B, Gandhi V (2009). Glucocorticoid resistance in a multiple myeloma cell line is regulated by a transcription elongation block in the glucocorticoid receptor gene (NR3C1). Br J Haematol. 144: 856-864.
29. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS, Jr. (1995). Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol. 15: 943-953.
30. Schlaghecke R, Beuscher D, Kornely E, Specker C (1994). Effects of glucocorticoids in rheumatoid arthritis. Diminished glucocorticoid receptors do not result in glucocorticoid resistance. Arthritis Rheum. 37: 1127-1131.
31. Schmidt S, Irving JA, Minto L, Matheson E, Nicholson L, Ploner A, et al., (2006). Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor. FASEB J. 20: 2600-2602.
32. Schwartz CL, Thompson EB, Gelber RD, Young ML, Chilton D, Cohen HJ, et al., (2001). Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia. J Clin Oncol. 19: 1040-1046.
33. Tanaka H, Akama H, Ichikawa Y, Makino I, Homma M (1992)Glucocorticoid receptor in patients with lupus nephritis: relationship between receptor levels in mononuclear leukocytes and effect of glucocorticoid therapy. J Rheumatol. 19: 878-883,
34. Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Wiercinski R, Stasiak-Barmuta A (2003). Expression of glucocorticoid receptors in mononuclear cells in nephrotic syndrome. Pediatr Nephrol. 18: 778-782.
35. Wochnik GM, Ruegg J, Abel GA, Schmidt U, Holsboer F, Rein T (2005). FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem. 280: 4609-4616.